Ads
related to: new psoriasis study- Before & After Pictures
View Biologic Psoriasis Results
For Clearer Skin Beyond Tomorrow.
- How Biologics Work
Watch the Video & See How This
Plaque Psoriasis Treatment Works.
- As Little as $0 per Dose
View Patient Copay Card Info
For A Psoriasis Treatment Option.
- Find Patient Resources
Learn About Services To Help Start
And Stay On Biologic Therapy.
- Before & After Pictures
Search results
Results From The WOW.Com Content Network
Brodalumab, sold under the brand name Siliq in the US and Kyntheum in the EU, is a human monoclonal antibody designed for the treatment of inflammatory diseases. [3] [4] [5]In February 2017, it received US FDA approval to treat moderate to severe plaque psoriasis in people who have not improved with other treatments.
Later on, in 2019 the 3-year study results of continuous treatment with tildrakizumab were published. Given that psoriasis is a chronic disease that requires lifelong treatment, data on long-term maintenance of clinical responses and long-term safety are of special interest. [15]
A retrospective cohort study, spanning from 2009 to 2020, also looked into the long-term outcomes of guttate psoriasis. [16] In this study nearly half of the 120 patients with new-onset guttate psoriasis experienced persistent disease, with some transitioning to the psoriasis vulgaris over time.
For premium support please call: 800-290-4726 more ways to reach us
Tapinarof, also known as benvitimod and sold under the brand name Vtama, is a medication used for the treatment of plaque psoriasis. [1] The medication is applied to the skin. [1] Besides its use in medicine, tapinarof is a naturally occurring compound found in bacterial symbionts of nematodes which has antibiotic properties. [2] [3]
AbbVie said it expects 2020 adjusted earnings of $9.61 to $9.71 per share, above analysts' estimates of $9.48. The profit forecast excludes any impact from the pending $63 billion Allergan deal ...
Ads
related to: new psoriasis study